» Articles » PMID: 26321659

Crosstalk Between Gut Microbiota and Dietary Lipids Aggravates WAT Inflammation Through TLR Signaling

Overview
Journal Cell Metab
Publisher Cell Press
Date 2015 Sep 1
PMID 26321659
Citations 428
Authors
Affiliations
Soon will be listed here.
Abstract

Dietary lipids may influence the abundance of circulating inflammatory microbial factors. Hence, inflammation in white adipose tissue (WAT) induced by dietary lipids may be partly dependent on their interaction with the gut microbiota. Here, we show that mice fed lard for 11 weeks have increased Toll-like receptor (TLR) activation and WAT inflammation and reduced insulin sensitivity compared with mice fed fish oil and that phenotypic differences between the dietary groups can be partly attributed to differences in microbiota composition. Trif(-/-) and Myd88(-/-) mice are protected against lard-induced WAT inflammation and impaired insulin sensitivity. Experiments in germ-free mice show that an interaction between gut microbiota and saturated lipids promotes WAT inflammation independent of adiposity. Finally, we demonstrate that the chemokine CCL2 contributes to microbiota-induced WAT inflammation in lard-fed mice. These results indicate that gut microbiota exacerbates metabolic inflammation through TLR signaling upon challenge with a diet rich in saturated lipids.

Citing Articles

Gut Microbiome Regulation of Gut Hormone Secretion.

Chao J, Coleman R, Keating D, Martin A Endocrinology. 2025; 166(4).

PMID: 40037297 PMC: 11879239. DOI: 10.1210/endocr/bqaf004.


Chronodisruption enhances inflammatory cytokine release from visceral adipose tissue in obesity.

Zinna L, Verde L, Tolla M, Barrea L, Parascandolo A, DAlterio F J Transl Med. 2025; 23(1):231.

PMID: 40011933 PMC: 11863425. DOI: 10.1186/s12967-025-06250-7.


Dietary Lipids, Gut Microbiota, and Their Metabolites: Insights from Recent Studies.

Mohammadi F, Rudkowska I Nutrients. 2025; 17(4).

PMID: 40004966 PMC: 11858126. DOI: 10.3390/nu17040639.


Therapeutic Strategies to Modulate Gut Microbial Health: Approaches for Chronic Metabolic Disorder Management.

Rondanelli M, Borromeo S, Cavioni A, Gasparri C, Gattone I, Genovese E Metabolites. 2025; 15(2).

PMID: 39997751 PMC: 11857149. DOI: 10.3390/metabo15020127.


Advancements in the Pathogenesis, Diagnosis, and Therapeutic Implications of Intestinal Bacteria.

Lu D, Ma X, Tao K, Lei H Curr Issues Mol Biol. 2025; 47(2).

PMID: 39996827 PMC: 11853859. DOI: 10.3390/cimb47020106.


References
1.
Wlotzka B, Leva S, Eschgfaller B, Burmeister J, Kleinjung F, Kaduk C . In vivo properties of an anti-GnRH Spiegelmer: an example of an oligonucleotide-based therapeutic substance class. Proc Natl Acad Sci U S A. 2002; 99(13):8898-902. PMC: 124395. DOI: 10.1073/pnas.132067399. View

2.
Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E . Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res. 2005; 46(11):2347-55. DOI: 10.1194/jlr.M500294-JLR200. View

3.
Backhed F, Manchester J, Semenkovich C, Gordon J . Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A. 2007; 104(3):979-84. PMC: 1764762. DOI: 10.1073/pnas.0605374104. View

4.
Larsson E, Tremaroli V, Lee Y, Koren O, Nookaew I, Fricker A . Analysis of gut microbial regulation of host gene expression along the length of the gut and regulation of gut microbial ecology through MyD88. Gut. 2011; 61(8):1124-31. PMC: 3388726. DOI: 10.1136/gutjnl-2011-301104. View

5.
Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal W, Strowig T . Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature. 2012; 482(7384):179-85. PMC: 3276682. DOI: 10.1038/nature10809. View